ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
9,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
10,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
10,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
11,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
13,1,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
13,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
15,1,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
15,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
17,1,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
17,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
18,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
20,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
21,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
21,4,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
22,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
22,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
22,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
22,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
22,7,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
23,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
23,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
23,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
23,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
23,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
24,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
24,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
24,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
24,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
26,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
26,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
26,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
27,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
27,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
28,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
30,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
30,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
30,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
30,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
30,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
30,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
30,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
30,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
30,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
30,15,Tic,Tic disorders,Changes in physical activity,Psych,N
31,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
31,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
31,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
33,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
33,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
34,1,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
34,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
34,3,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
35,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
35,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
36,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
36,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
37,1,Clubbing,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
37,3,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
37,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
38,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
38,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
39,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
44,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
46,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
46,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
46,3,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
47,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
47,3,Headache,Headaches NEC,Headaches,Nerv,N
47,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,1,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
48,2,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
48,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
49,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,3,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
49,4,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
49,5,Spider naevus,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
49,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,7,Ultrasound liver abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
50,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
50,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
51,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
52,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
52,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
54,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
54,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
55,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
55,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
56,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
56,2,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
56,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
56,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
57,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
57,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
57,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
58,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
58,3,Hepatic atrophy,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,4,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
58,5,Non-cirrhotic portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
58,6,Portal fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
58,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
58,8,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
59,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
59,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
59,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
59,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
60,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
60,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
61,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
61,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
61,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
61,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
62,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
62,2,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
62,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
62,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,5,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
63,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
63,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
64,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
65,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
65,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
65,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
66,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
67,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
68,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
68,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
68,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
69,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
69,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
69,4,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
69,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,6,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
69,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
70,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
